Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon

Mark R. Walter, Ronald Bordens, Tattanahalli L. Nagabhushan, Bryan R.G. Williams, Ronald B. Herberman, Charles A. Dinarello, Ernest C. Borden, Paul P. Trotta, Sidney Pestka, Lawrence Pfeffer

Research output: Contribution to journalReview article

32 Citations (Scopus)

Abstract

Recombinant alfa interferons (IFN-αs) are approved worldwide for the treatment of a variety of cancers and diseases of virologic origin. A series of recent advances in the molecular characterization of recombinant IFN-αs have allowed the determination of the three-dimensional IFN-α(2b) structure by high-resolution x-ray crystallography. We review here recent developments in our understanding of the molecular and physicochemical properties of recombinant IFN-α, including our current state of knowledge of the IFN-α gene family and the multiple species of human leukocyte IFN. Based on the reported three-dimensional structure of IFN-α(2b) we propose a molecular model for the IFN-α(2b) receptor complex and predict models for the naturally occurring subtypes IFN-α1 and lFN-α8, as well as the synthetic, non-naturally occurring consensus IFN. Such models provide molecular insights into the mechanism of action of IFN-α.

Original languageEnglish (US)
Pages (from-to)143-154
Number of pages12
JournalCancer Biotherapy and Radiopharmaceuticals
Volume13
Issue number3
DOIs
StatePublished - Jan 1 1998

Fingerprint

Molecular Models
Anniversaries and Special Events
Interferon-alpha
Interferons
Crystallography
Leukocytes
X-Rays
Genes
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Pharmacology
  • Cancer Research

Cite this

Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon. / Walter, Mark R.; Bordens, Ronald; Nagabhushan, Tattanahalli L.; Williams, Bryan R.G.; Herberman, Ronald B.; Dinarello, Charles A.; Borden, Ernest C.; Trotta, Paul P.; Pestka, Sidney; Pfeffer, Lawrence.

In: Cancer Biotherapy and Radiopharmaceuticals, Vol. 13, No. 3, 01.01.1998, p. 143-154.

Research output: Contribution to journalReview article

Walter, Mark R. ; Bordens, Ronald ; Nagabhushan, Tattanahalli L. ; Williams, Bryan R.G. ; Herberman, Ronald B. ; Dinarello, Charles A. ; Borden, Ernest C. ; Trotta, Paul P. ; Pestka, Sidney ; Pfeffer, Lawrence. / Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon. In: Cancer Biotherapy and Radiopharmaceuticals. 1998 ; Vol. 13, No. 3. pp. 143-154.
@article{ebdc9a0331404d41bd80df7d0e232f39,
title = "Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon",
abstract = "Recombinant alfa interferons (IFN-αs) are approved worldwide for the treatment of a variety of cancers and diseases of virologic origin. A series of recent advances in the molecular characterization of recombinant IFN-αs have allowed the determination of the three-dimensional IFN-α(2b) structure by high-resolution x-ray crystallography. We review here recent developments in our understanding of the molecular and physicochemical properties of recombinant IFN-α, including our current state of knowledge of the IFN-α gene family and the multiple species of human leukocyte IFN. Based on the reported three-dimensional structure of IFN-α(2b) we propose a molecular model for the IFN-α(2b) receptor complex and predict models for the naturally occurring subtypes IFN-α1 and lFN-α8, as well as the synthetic, non-naturally occurring consensus IFN. Such models provide molecular insights into the mechanism of action of IFN-α.",
author = "Walter, {Mark R.} and Ronald Bordens and Nagabhushan, {Tattanahalli L.} and Williams, {Bryan R.G.} and Herberman, {Ronald B.} and Dinarello, {Charles A.} and Borden, {Ernest C.} and Trotta, {Paul P.} and Sidney Pestka and Lawrence Pfeffer",
year = "1998",
month = "1",
day = "1",
doi = "10.1089/cbr.1998.13.143",
language = "English (US)",
volume = "13",
pages = "143--154",
journal = "Cancer Biotherapy and Radiopharmaceuticals",
issn = "1084-9785",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon

AU - Walter, Mark R.

AU - Bordens, Ronald

AU - Nagabhushan, Tattanahalli L.

AU - Williams, Bryan R.G.

AU - Herberman, Ronald B.

AU - Dinarello, Charles A.

AU - Borden, Ernest C.

AU - Trotta, Paul P.

AU - Pestka, Sidney

AU - Pfeffer, Lawrence

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Recombinant alfa interferons (IFN-αs) are approved worldwide for the treatment of a variety of cancers and diseases of virologic origin. A series of recent advances in the molecular characterization of recombinant IFN-αs have allowed the determination of the three-dimensional IFN-α(2b) structure by high-resolution x-ray crystallography. We review here recent developments in our understanding of the molecular and physicochemical properties of recombinant IFN-α, including our current state of knowledge of the IFN-α gene family and the multiple species of human leukocyte IFN. Based on the reported three-dimensional structure of IFN-α(2b) we propose a molecular model for the IFN-α(2b) receptor complex and predict models for the naturally occurring subtypes IFN-α1 and lFN-α8, as well as the synthetic, non-naturally occurring consensus IFN. Such models provide molecular insights into the mechanism of action of IFN-α.

AB - Recombinant alfa interferons (IFN-αs) are approved worldwide for the treatment of a variety of cancers and diseases of virologic origin. A series of recent advances in the molecular characterization of recombinant IFN-αs have allowed the determination of the three-dimensional IFN-α(2b) structure by high-resolution x-ray crystallography. We review here recent developments in our understanding of the molecular and physicochemical properties of recombinant IFN-α, including our current state of knowledge of the IFN-α gene family and the multiple species of human leukocyte IFN. Based on the reported three-dimensional structure of IFN-α(2b) we propose a molecular model for the IFN-α(2b) receptor complex and predict models for the naturally occurring subtypes IFN-α1 and lFN-α8, as well as the synthetic, non-naturally occurring consensus IFN. Such models provide molecular insights into the mechanism of action of IFN-α.

UR - http://www.scopus.com/inward/record.url?scp=7344221471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7344221471&partnerID=8YFLogxK

U2 - 10.1089/cbr.1998.13.143

DO - 10.1089/cbr.1998.13.143

M3 - Review article

C2 - 10850350

AN - SCOPUS:7344221471

VL - 13

SP - 143

EP - 154

JO - Cancer Biotherapy and Radiopharmaceuticals

JF - Cancer Biotherapy and Radiopharmaceuticals

SN - 1084-9785

IS - 3

ER -